Monoclonal antibodies for the treatment of Graves' ophthalmopathy: A systematic review and meta-analysis.

Fatani, Wed A; Hamdan, Dalia M; Taher, Nada O; Alsharef, Jawaher F; Aldubi, Riyam M; Alwagdani, Alhanouf M; Alhothali, Taif N; Khan, Zia U

Fatani, Wed A; Hamdan, Dalia M; Taher, Nada O; Alsharef, Jawaher F; Aldubi, Riyam M; Alwagdani, Alhanouf M; Alhothali, Taif N; Khan, Zia U.

Afiliación

Fatani WA; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Hamdan DM; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Taher NO; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Alsharef JF; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Aldubi RM; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Alwagdani AM; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Alhothali TN; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
Khan ZU; King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.

Saudi J Ophthalmol ; 37(2): 137-148, 2023.

Article en En | MEDLINE | ID: mdl-37492211

Palabras clave

Graves'; ophthalmopathy; orbitopathy; rituximab; teprotumumab; thyroid eye disease; tocilizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Saudi J Ophthalmol Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google